AKZA - Akzo Nobel N.V.
AMS
->
Basic Materials
->
Specialty Chemicals
Amsterdam,
Netherlands
Type: Equity
AKZA price evolution
AKZA
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2996 | $3053 | $2953 | $2483 |
| Inventory | $1805 | $1836 | $1779 | $1649 |
| Total current assets | $6981 | $6058 | $5830 | $6044 |
| Long term investments | ||||
| Property, plant & equipment | $2332 | $2333 | $2324 | $2296 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $15348 | $14484 | $14309 | $14558 |
| Current liabilities | ||||
| Accounts payable | $2928 | $2962 | $2896 | $2933 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $5785 | $5506 | $5197 | $5706 |
| Long term debt | $3672 | $3182 | $3183 | $3165 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $10771 | $10014 | $9733 | $10236 |
| Shareholders' equity | ||||
| Retained earnings | $5185 | $5016 | $5110 | $4948 |
| Other shareholder equity | -$693 | -$631 | -$619 | -$711 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1152 | $1606 | ||
| Short term investments | $58 | $250 | ||
| Net receivables | $2483 | $2389 | $2488 | $2009 |
| Inventory | $1649 | $1843 | $1650 | $1159 |
| Total current assets | $6044 | $6244 | $5348 | $5064 |
| Long term investments | $178 | $243 | ||
| Property, plant & equipment | $2296 | $2259 | $2104 | $1945 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14558 | $14741 | $13878 | $13177 |
| Current liabilities | ||||
| Accounts payable | $2933 | $2319 | $2376 | $2032 |
| Deferred revenue | ||||
| Short long term debt | $754 | $5 | ||
| Total current liabilities | $5706 | $5746 | $4869 | $3093 |
| Long term debt | $3165 | $3332 | $1994 | $2533 |
| Total noncurrent liabilities | $2771 | |||
| Total debt | ||||
| Total liabilities | $10236 | $10408 | $8242 | $7227 |
| Shareholders' equity | ||||
| Retained earnings | $4948 | $4936 | $5846 | $794 |
| Other shareholder equity | -$711 | -$690 | -$512 | $4857 |
| Total shareholder equity | $5425 | $5746 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10668 | $10846 | $9587 | $8530 |
| Cost of revenue | $5732 | $4745 | ||
| Gross Profit | $4234 | $3923 | $3855 | $3785 |
| Operating activities | ||||
| Research & development | $238 | |||
| Selling, general & administrative | $2791 | $2565 | ||
| Total operating expenses | $3205 | $3215 | $8456 | $7553 |
| Operating income | $1131 | $977 | ||
| Income from continuing operations | ||||
| EBIT | $1131 | $977 | ||
| Income tax expense | $296 | $214 | $246 | $241 |
| Interest expense | -$96 | -$137 | -$74 | -$76 |
| Net income | ||||
| Net income | $442 | $352 | $829 | $630 |
| Income (for common shares) | $829 | $630 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$98 | $184 | $219 | -$144 |
| Financing activities | ||||
| Dividends paid | -$286 | -$281 | -$8 | -$368 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $316 | -$508 | -$581 | -$827 |
| Effect of exchange rate | -$39 | -$18 | -$3 | -$94 |
| Change in cash and equivalents | $450 | -$365 | -$538 | $55 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $829 | $630 | ||
| Operating activities | ||||
| Depreciation | $351 | $361 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $604 | $1217 | ||
| Investing activities | ||||
| Capital expenditures | -$288 | -$258 | ||
| Investments | $191 | -$112 | ||
| Total cash flows from investing | -$144 | -$1095 | -$134 | -$427 |
| Financing activities | ||||
| Dividends paid | -$368 | -$379 | -$364 | -$366 |
| Sale and purchase of stock | ||||
| Net borrowings | $553 | $631 | ||
| Total cash flows from financing | -$827 | $1141 | -$974 | -$353 |
| Effect of exchange rate | -$94 | -$14 | $35 | -$66 |
| Change in cash and equivalents | $55 | $286 | -$469 | $371 |
News
Fundamentals
| Market cap | $9.70B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 170.81M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.21 |
| Quick ratio | 0.89 |